Skip to main content
Top
Published in: Annals of Hematology 3/2014

01-03-2014 | Original Article

Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study

Authors: Nele Vermaete, Pascal Wolter, Gregor Verhoef, Rik Gosselink

Published in: Annals of Hematology | Issue 3/2014

Login to get access

Abstract

Fatigue is a common and distressing symptom in cancer patients, especially in lymphoma patients. One hypothesized mechanism in the etiology of fatigue is a vicious circle between fatigue, physical inactivity, and deconditioning. However, the natural evolution of physical activity and physical fitness over the course of treatment is unknown. Therefore, the aim of this longitudinal study was to assess fatigue, physical activity, and physical fitness in lymphoma patients before, during, and after treatment. Fatigue was measured with the EORTC-QLQ-C30, physical activity with an accelerometer, and physical fitness with a maximal incremental cycle ergometer test, 6-min walking distance test, and muscle strength measurements. Differences between the three measurement moments and baseline differences between Hodgkin lymphoma and non-Hodgkin lymphoma, early and advanced disease, were analyzed. Twenty-nine patients were included. Functional exercise capacity and quadriceps force were impaired before the start of treatment (86 ± 15 and 82 ± 16 % of predicted value, respectively). Over the course of treatment, significant declines were found in hemoglobin, quadriceps force, handgrip force, and maximal oxygen uptake, while patients reported more fatigue (p values < 0.016). Fatigue was significantly correlated with hemoglobin (r = −0.49), physical activity (r = 0.81), and physical functioning (r = −0.44). Large interindividual variations were found. The present study partially confirmed the hypothesized vicious circle between fatigue, physical inactivity, and deconditioning. Further research with larger samples and longer follow-up is needed to identify factors associated with individual variation in the evolution of fatigue, physical activity, and physical fitness.
Literature
1.
go back to reference Hoffbrand AV, Moss PAH (2011) Hodgkin lymphoma. In: Hoffbrand AV (ed) Essential haematology, 6th edn. Wiley-Blackwell, New Jersey, pp 245–252 Hoffbrand AV, Moss PAH (2011) Hodgkin lymphoma. In: Hoffbrand AV (ed) Essential haematology, 6th edn. Wiley-Blackwell, New Jersey, pp 245–252
2.
go back to reference American Cancer Society (2012) Cancer facts & figures 2012. American Cancer Society, Atlanta American Cancer Society (2012) Cancer facts & figures 2012. American Cancer Society, Atlanta
3.
go back to reference Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRef Ahlberg K, Ekman T, Gaston-Johansson F, Mock V (2003) Assessment and management of cancer-related fatigue in adults. Lancet 362:640–650PubMedCrossRef
4.
go back to reference Liu RD, Chinapaw MJ, Huijgens PC, van Mechelen W (2009) Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review. Cancer Treat Rev 35:185–192PubMedCrossRef Liu RD, Chinapaw MJ, Huijgens PC, van Mechelen W (2009) Physical exercise interventions in haematological cancer patients, feasible to conduct but effectiveness to be established: a systematic literature review. Cancer Treat Rev 35:185–192PubMedCrossRef
5.
go back to reference Ganz PA, Bower JE (2007) Cancer related fatigue: a focus on breast cancer and Hodgkin’s disease survivors. Acta Oncol 46:474–479PubMedCrossRef Ganz PA, Bower JE (2007) Cancer related fatigue: a focus on breast cancer and Hodgkin’s disease survivors. Acta Oncol 46:474–479PubMedCrossRef
6.
go back to reference Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005) Fatigue in long-term Hodgkin’s disease survivors: a follow-up study. J Clin Oncol 23:6587–6595PubMedCrossRef Hjermstad MJ, Fossa SD, Oldervoll L, Holte H, Jacobsen AB, Loge JH (2005) Fatigue in long-term Hodgkin’s disease survivors: a follow-up study. J Clin Oncol 23:6587–6595PubMedCrossRef
7.
go back to reference Vermaete N, Wolter P, Verhoef G, Gosselink R (2013) Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. Ann Hematol 92(8):1007–1021PubMedCrossRef Vermaete N, Wolter P, Verhoef G, Gosselink R (2013) Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. Ann Hematol 92(8):1007–1021PubMedCrossRef
8.
go back to reference Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, Tankel K, Basi S, Chua N, Mazurek A, Reiman T (2009) Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 27:4605–4612PubMedCrossRef Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, Tankel K, Basi S, Chua N, Mazurek A, Reiman T (2009) Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 27:4605–4612PubMedCrossRef
9.
go back to reference Vallance JK, Courneya KS, Jones LW, Reiman T (2005) Differences in quality of life between non-Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology 14:979–991PubMedCrossRef Vallance JK, Courneya KS, Jones LW, Reiman T (2005) Differences in quality of life between non-Hodgkin’s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology 14:979–991PubMedCrossRef
10.
go back to reference Habermann TM, Janney CA, Clark MM, Rummans TA, Sloan JS, Cerhan JR, Geyer SM, Thomas RJ (2005) A pilot study of physical activity level and mood among long-term lymphoma survivors. Blood 106(11):253B–253B Habermann TM, Janney CA, Clark MM, Rummans TA, Sloan JS, Cerhan JR, Geyer SM, Thomas RJ (2005) A pilot study of physical activity level and mood among long-term lymphoma survivors. Blood 106(11):253B–253B
11.
go back to reference Bellizzi KM, Rowland JH, Arora NK, Hamilton AS, Miller MF, Aziz NM (2009) Physical activity and quality of life in adult survivors of non-Hodgkin’s lymphoma. J Clin Oncol 27:960–966PubMedCrossRef Bellizzi KM, Rowland JH, Arora NK, Hamilton AS, Miller MF, Aziz NM (2009) Physical activity and quality of life in adult survivors of non-Hodgkin’s lymphoma. J Clin Oncol 27:960–966PubMedCrossRef
12.
go back to reference (1996) Surgeon General’s report on physical activity and health. From the Centers for Disease Control and Prevention. JAMA 276:522 (1996) Surgeon General’s report on physical activity and health. From the Centers for Disease Control and Prevention. JAMA 276:522
13.
go back to reference Page E, Assouline D, Durand C, Brun O, Coeffic D, Fric D, Garnier C, Leyronnas C, Alcalay V, Aguilaniu B (2006) Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment. Ann Hematol 85:857–861PubMedCrossRef Page E, Assouline D, Durand C, Brun O, Coeffic D, Fric D, Garnier C, Leyronnas C, Alcalay V, Aguilaniu B (2006) Stage-related changes in functional capacity in Hodgkin’s disease: assessment by cardiopulmonary exercise testing before initiation of treatment. Ann Hematol 85:857–861PubMedCrossRef
14.
go back to reference Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef Oldervoll LM, Kaasa S, Knobel H, Loge JH (2003) Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors—results from a pilot study. Eur J Cancer 39:57–63PubMedCrossRef
15.
go back to reference Elbl L, Vasova I, Tomaskova I, Jedlicka F, Kral Z, Navratil M, Smardova L, Wagnerova B, Vorlicek J (2006) Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults. Leuk Lymphoma 47:843–851PubMedCrossRef Elbl L, Vasova I, Tomaskova I, Jedlicka F, Kral Z, Navratil M, Smardova L, Wagnerova B, Vorlicek J (2006) Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults. Leuk Lymphoma 47:843–851PubMedCrossRef
16.
go back to reference Cotes JE, leathart GL (1993) Lung function: assessment and application in medicine. Blackwell, London Cotes JE, leathart GL (1993) Lung function: assessment and application in medicine. Blackwell, London
17.
go back to reference Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ (1972) Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 42:325–335PubMed Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ (1972) Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusion capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 42:325–335PubMed
18.
go back to reference Quanjer PH (2003) Lung function tests. Medicina (B Aires) 63:459 Quanjer PH (2003) Lung function tests. Medicina (B Aires) 63:459
20.
go back to reference Langer D, Gosselink R, Sena R, Burtin C, Decramer M, Troosters T (2009) Validation of two activity monitors in patients with COPD. Thorax 64:641–642PubMedCrossRef Langer D, Gosselink R, Sena R, Burtin C, Decramer M, Troosters T (2009) Validation of two activity monitors in patients with COPD. Thorax 64:641–642PubMedCrossRef
21.
go back to reference Jones NL (1988) Normal standards. Clinical exercise testing. Saunders, Philadelphia Jones NL (1988) Normal standards. Clinical exercise testing. Saunders, Philadelphia
22.
go back to reference Troosters T, Gosselink R, Decramer M (1999) Six minute walking distance in healthy elderly subjects. Eur Respir J 14:270–274PubMedCrossRef Troosters T, Gosselink R, Decramer M (1999) Six minute walking distance in healthy elderly subjects. Eur Respir J 14:270–274PubMedCrossRef
23.
go back to reference Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696–702PubMed Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696–702PubMed
24.
go back to reference Rochester DF, Arora NS (1983) Respiratory muscle failure. Med Clin N Am 67:573–597PubMed Rochester DF, Arora NS (1983) Respiratory muscle failure. Med Clin N Am 67:573–597PubMed
25.
go back to reference Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980PubMedCrossRef Gosselink R, Troosters T, Decramer M (1996) Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 153:976–980PubMedCrossRef
26.
go back to reference Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S (1985) Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 66:69–74PubMed Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S (1985) Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 66:69–74PubMed
27.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
28.
go back to reference Bauwens S, Baillon C, Distelmans W, Theuns P (2009) The ‘distress barometer’: validation of method of combining the distress thermometer with a rated complaint scale. Psychooncology 18:534–542PubMedCrossRef Bauwens S, Baillon C, Distelmans W, Theuns P (2009) The ‘distress barometer’: validation of method of combining the distress thermometer with a rated complaint scale. Psychooncology 18:534–542PubMedCrossRef
29.
go back to reference Martin WG, Ristow KM, Habermann TM, Colgan JP, Witzig TE, Ansell SM (2005) Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol 23:7614–7620PubMedCrossRef Martin WG, Ristow KM, Habermann TM, Colgan JP, Witzig TE, Ansell SM (2005) Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol 23:7614–7620PubMedCrossRef
30.
go back to reference Caspersen CJ, Pereira MA, Curran KM (2000) Changes in physical activity patterns in the United States, by sex and cross-sectional age. Med Sci Sports Exerc 32:1601–1609PubMedCrossRef Caspersen CJ, Pereira MA, Curran KM (2000) Changes in physical activity patterns in the United States, by sex and cross-sectional age. Med Sci Sports Exerc 32:1601–1609PubMedCrossRef
31.
go back to reference Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116:1081–1093PubMedCrossRef Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A (2007) Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116:1081–1093PubMedCrossRef
32.
go back to reference Guthold R, Ono T, Strong KL, Chatterji S, Morabia A (2008) Worldwide variability in physical inactivity a 51-country survey. Am J Prev Med 34:486–494PubMedCrossRef Guthold R, Ono T, Strong KL, Chatterji S, Morabia A (2008) Worldwide variability in physical inactivity a 51-country survey. Am J Prev Med 34:486–494PubMedCrossRef
33.
go back to reference Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS (2005) Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 97:422–430PubMedCrossRef Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V, Tonkin KS (2005) Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 97:422–430PubMedCrossRef
34.
go back to reference Jones LW, Courneya KS, Vallance JK, Ladha AB, Mant MJ, Belch AR, Stewart DA, Reiman T (2004) Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 12:780–788PubMedCrossRef Jones LW, Courneya KS, Vallance JK, Ladha AB, Mant MJ, Belch AR, Stewart DA, Reiman T (2004) Association between exercise and quality of life in multiple myeloma cancer survivors. Support Care Cancer 12:780–788PubMedCrossRef
35.
go back to reference Rogers LQ, Courneya KS, Robbins KT, Malone J, Seiz A, Koch L, Rao K, Nagarkar M (2006) Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer 14:1012–1019PubMedCrossRef Rogers LQ, Courneya KS, Robbins KT, Malone J, Seiz A, Koch L, Rao K, Nagarkar M (2006) Physical activity and quality of life in head and neck cancer survivors. Support Care Cancer 14:1012–1019PubMedCrossRef
36.
go back to reference Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R (2007) Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol 18:1957–1962PubMedCrossRef Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R (2007) Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol 18:1957–1962PubMedCrossRef
37.
go back to reference Gilliam LA, Ferreira LF, Bruton JD, Moylan JS, Westerblad H, St Clair DK, Reid MB (2009) Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle. J Appl Physiol 107:1935–1942PubMedCrossRef Gilliam LA, Ferreira LF, Bruton JD, Moylan JS, Westerblad H, St Clair DK, Reid MB (2009) Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle. J Appl Physiol 107:1935–1942PubMedCrossRef
38.
go back to reference Reid MB, Lannergren J, Westerblad H (2002) Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166:479–484PubMedCrossRef Reid MB, Lannergren J, Westerblad H (2002) Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 166:479–484PubMedCrossRef
39.
go back to reference Smuder AJ, Kavazis AN, Min K, Powers SK (2011) Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 110:935–942PubMedCrossRef Smuder AJ, Kavazis AN, Min K, Powers SK (2011) Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 110:935–942PubMedCrossRef
40.
go back to reference Gilbert MR (2008) Neurologic complications. In: Abeloff MD (ed) Abeloff’s clinical oncology. Churchill Livingstone, Philadelphia, pp 945–967CrossRef Gilbert MR (2008) Neurologic complications. In: Abeloff MD (ed) Abeloff’s clinical oncology. Churchill Livingstone, Philadelphia, pp 945–967CrossRef
41.
go back to reference Sioka C, Kyritsis AP (2009) Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 63:761–767PubMedCrossRef Sioka C, Kyritsis AP (2009) Central and peripheral nervous system toxicity of common chemotherapeutic agents. Cancer Chemother Pharmacol 63:761–767PubMedCrossRef
42.
43.
go back to reference Armstrong K, Rakhit D, Jeffriess L, Johnson D, Leano R, Prins J, Garske L, Marwick T, Isbel N (2006) Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clin J Am Soc Nephrol 1:1275–1283PubMedCrossRef Armstrong K, Rakhit D, Jeffriess L, Johnson D, Leano R, Prins J, Garske L, Marwick T, Isbel N (2006) Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clin J Am Soc Nephrol 1:1275–1283PubMedCrossRef
44.
go back to reference Foubert J (2006) Cancer-related anaemia and fatigue: assessment and treatment. Nurs Stand 20:50–57PubMedCrossRef Foubert J (2006) Cancer-related anaemia and fatigue: assessment and treatment. Nurs Stand 20:50–57PubMedCrossRef
45.
go back to reference Shelton ML, Lee JQ, Morris GS, Massey PR, Kendall DG, Munsell MF, Anderson KO, Simmonds MJ, Giralt SA (2009) A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients. Psychooncology 18:353–359PubMedCrossRef Shelton ML, Lee JQ, Morris GS, Massey PR, Kendall DG, Munsell MF, Anderson KO, Simmonds MJ, Giralt SA (2009) A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients. Psychooncology 18:353–359PubMedCrossRef
46.
go back to reference Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK (2011) Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transpl 46:1245–1255CrossRef Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK (2011) Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transpl 46:1245–1255CrossRef
47.
go back to reference Al-Majid S, Waters H (2008) The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs 10:7–20PubMedCrossRef Al-Majid S, Waters H (2008) The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs 10:7–20PubMedCrossRef
48.
go back to reference Clarkson PM, Kaufman SA (2010) Should resistance exercise be recommended during breast cancer treatment? Med Hypotheses 75:192–195PubMedCrossRef Clarkson PM, Kaufman SA (2010) Should resistance exercise be recommended during breast cancer treatment? Med Hypotheses 75:192–195PubMedCrossRef
Metadata
Title
Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study
Authors
Nele Vermaete
Pascal Wolter
Gregor Verhoef
Rik Gosselink
Publication date
01-03-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 3/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1881-3

Other articles of this Issue 3/2014

Annals of Hematology 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.